Regulatory Insights

31. FDA Guidance On Payment And Reimbursement To Research Subjects 12/5/2025

    Learn how ethical, fair, and timely payment and reimbursement strategies can support participants, enhance trial accessibility, and uphold regulatory and IRB standards.

32. Does 'The Belmont Report' Provide Guidance For Patient Stipends? 12/5/2025

    Consider implementing fair and flexible stipend models that account for individual burdens to enhance diversity, equity, and participation in clinical trials.

33. Navigating The AI And Regulatory Frontier For Clinical Operations, Supply 12/5/2025

    AI is transforming clinical trials. Learn how strategic adoption and cultural readiness can unlock efficiency, resilience, and compliance in an evolving global landscape.

34. Regulatory Comparisons For Starting First-In-Human Clinical Trials 12/4/2025

    Engage early with regulatory and clinical experts to navigate evolving global requirements and ensure your first-in-human strategy supports downstream development and multinational approvals.

35. How Mobile Clinics Advance Diversity In Clinical Research 12/4/2025

    Mobile clinics reduce participation barriers, enable more inclusive trials, deliver representative data, speed timelines, and advance equity in research.

36. AI In Regulatory Medical Writing: Balancing Innovation With Human Expertise 12/2/2025

    Artificial intelligence is reshaping regulatory medical writing by accelerating document development while maintaining compliance and scientific rigor, creating faster, regulator-ready submissions without compromising quality.

37. Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology 11/24/2025

    Gain a clearer view of the scientific, operational, and regulatory forces propelling the next wave of oncology innovation — and what they mean for sponsors advancing cutting-edge cancer therapies.

38. ICH GCP E6(R3) Implementation: Practical Approaches And Real-World Considerations 11/21/2025

    Access the full brief to learn how a phased, 12–18-month approach can help you meet ICH GCP E6(R3) requirements with confidence and avoid the costly pitfalls many organizations overlook.

39. Your Neurological Gene Therapy Trial's Secret Weapon: Caregiver Support 11/20/2025

    When it comes to neurological gene therapy trials, sponsors must prepare for participants losing the capacity to consent by enlisting the support of caregivers and legally authorized representatives.

40. Unlock Robust And Reliable Stability Data With The Right Partner 11/19/2025

    Stability testing is essential to ensuring your drug’s stability, potency, efficacy, and safety under different controlled conditions throughout development, manufacturing, and life cycle management.